Illumina grabs GenoLogics in IT deal; Roche eyes FDA approval for cancer companion Dx;

> Illumina ($ILMN) snatched up GenoLogics Life Sciences Software to get its hands on the company's lab information management systems. Release

> Roche ($RHHBY) submitted paperwork to the FDA for premarket approval (PMA) of its companion diagnostic for AstraZeneca's ($AZN) non-small cell lung cancer drug. Statement

> Quest Diagnostics ($DGX) is teaming up with the Perinatal Quality Foundation to advance noninvasive prenatal screening in the U.S. More

> Roche Diagnostics cut the ribbon on its new Asia Pacific HQ and regional Center of Excellence in Singapore. Story

> French diagnostics company Novacyt roped in €5 million ($5.4 million) in funding to support its growth initiatives. Statement

And Finally… The U.S. Preventive Services Task Force is recommending that all women who are pregnant or are within a year of giving birth should be screened for perinatal depression. Story

Suggested Articles

Grail published new data showing that its cancer-screening blood test is now able to spot more than 50 types of the disease and across all stages.

Battelle received an emergency go-ahead from the FDA over the weekend to deploy its decontamination system for N95 respirator masks.

The limited supply of ventilators is one of the chief concerns facing hospitals as they prepare for more COVID-19 cases.